Tenet Healthcare's stock surged 23% on Friday, marking its biggest single-day rise since February. The jump followed a quarterly report that significantly exceeded Wall Street's expectations and boosted the company's full-year earnings forecast.
Strong Earnings Power the Rally
For the second quarter, Tenet delivered adjusted earnings per share of $6.12, well above analysts' estimate of $4.26. Revenue climbed 6.8% to $5.63 billion, surpassing the predicted $5.43 billion. This performance was driven by notable margin expansion in hospitals and strong pricing power in ambulatory services.
The company raised its full-year adjusted EPS guidance to a range between $20.30 and $21.69, a substantial increase from the previous outlook of $16.38 to $18.68. It also lifted its net operating revenue forecast to between $21.9 billion and $22.5 billion, up from $21.5 billion to $22.3 billion. At the midpoint, these projections outpace consensus estimates, aiming for $17.94 per share and $21.97 billion in revenue.
In contrast, rival HCA Healthcare posted a more muted reaction with shares up 3.7%. HCA had pre-announced its Q2 results, which showed adjusted EPS just above expectations at $7.59 and revenue up 9% to $20.23 billion. However, HCA lowered its full-year EPS guidance to $28.70 $30.50 from $29.10 $31.50, citing challenges including a rise in uninsured patients affecting pre-tax income by an estimated $400 million.
Following Tenet's impressive report, Barclays increased its price target to $271 from $240, maintaining an Overweight rating on the stock.
The strong earnings beat and upgraded guidance have set Tenet apart from peers, with the stock's 23% gain standing out as the broader market saw only slight declines on the same day.
This content is for informational purposes and does not constitute financial advice.
